440
Participants
Start Date
January 3, 2024
Primary Completion Date
March 30, 2026
Study Completion Date
September 30, 2026
Atorvastatin 20mg
Participants will receive oral atorvastatin 20mg daily for 16 weeks
Atorvastatin 40mg
Participants will receive oral atorvastatin 40mg daily for 16 weeks
Atorvastatin 60mg
Participants will receive oral atorvastatin 60 mg daily for 16 weeks
Fixed dose combination of Rifampicin (R) Isoniazid (H) Pyrazinamide (Z) Ethambutol (E)
Participants will receive 8 weeks of daily oral treatment with rifampin, isoniazid, pyrazinamide, ethambutol, followed by 16 weeks of daily oral treatment with rifampin, isoniazid
RECRUITING
Bowen University Teaching Hospital, Iwo
RECRUITING
National Tuberculosis Reference Laboratory, Zaria
RECRUITING
Federal Teaching Hospital, Katsina
RECRUITING
Federal Medical Center, Keffi
RECRUITING
Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife
RECRUITING
University College Hospital, Ibadan
RECRUITING
Usman Danfodio University, Sokoto
RECRUITING
University of Abuja Teaching Hospital, Gwagwalada
Open Philanthropy
OTHER
Obafemi Awolowo University Teaching Hospital
OTHER